Searchable abstracts of presentations at key conferences in endocrinology

ea0003p8 | Bone | BES2002

Availability of a reliable marker of bone resorption in serum, C-terminal cross-linking telopeptide of type I collagen, for evaluation of metabolic bone disease

Fitzgibbon M , Murray B , McBrinn Y , O'Shea D , McKenna M , McKenna T

In contrast to bone formation biomarkers, reliable bone resorption biomarkers have not been available in serum. Recently, automated measurement of C-terminal cross-linking telopeptide of type I collagen (CTX-I), has been promoted as a reliable indicator of bone resorption. The objective of the study was to examine the correlation of CTX-I, with the traditional urinary markers, N-telopeptide of type I collagen (NTX-I) and deoxypyridinoline (DPD) in a series of patients with Pag...

ea0003p9 | Bone | BES2002

Development of bone remodelling balance and turnover indices in patients with metabolic bone disease

Murray B , Fitzgibbon M , McBrinn Y , O'Shea D , McKenna M , McKenna T

Measurement of the various available bone formation and resorption markers provide insights into different aspects of the bone metabolism process. Interpretation of bone biomarkers in a clinical setting is complex. Analysis of formation markers including bone alkaline phosphatase, procollagen type 1 propeptide and intact osteocalcin and resorption markers including free deoxypyridinoline and N-terminal cross-linking telopeptide of type 1 collagen were performed. From the inter...